News: Allergy Therapeutics Plc (AGY.L)

AGY.L on London Stock Exchange

14.75GBp
18 Dec 2009
Price Change (% chg)

0.00p (+0.00%)
Prev Close
14.75p
Open
14.75p
Day's High
14.75p
Day's Low
14.75p
Volume
0
Avg. Vol
16,980
52-wk High
25.00p
52-wk Low
6.00p

view news for:
Select another date:

Thu, Sep 10 2009

STOCKS NEWS EUROPE-Glaxo vaccine news lifts Allergy shares

Allergy Therapeutics shares gain 3.4 percent, buoyed by news GlaxoSmithKline's cervical cancer vaccine Cervarix, which contains the same adjuvant as Allergy's Pollinex Quattro, has been recommended for approval by U.S. experts.

STOCKS NEWS EUROPE-Allergy Therapeutics falls on placing

Shares in hayfever vaccine specialist Allergy Therapeutics tumble 14 percent to 15.3 pence per share after the company announces that it is raising up to 22.4 million pounds through a placing at 12 pence per share.

STOCKS NEWS EUROPE-Allergy Therapeutics falls on placing

Shares in Allergy Therapeutics tumble 8.7 percent to 15.75 pence after the hayfever vaccine specialist announces that it is raising up to 22.4 million pounds by placing about 163.5 million shares at 12 pence per share.

STOCKS NEWS EUROPE-Allergy Therapeutics soars on debt talk

Shares in hayfever specialist Allergy Therapeutics soar 39 percent on talk that the company is poised to announce a renegotiation of its debt.

UPDATE 1-Allergy Therapeutics signs Canada deal

* Signed with privately held Nycomed for older Pollinex R

Select another date:

Press Releases

view news for: